CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. If you think you’ve been targeted by a scam, you can get ...